ohp | 25301
17-OH-progesterone (LCMS)
Keywords
17-Hydroxyprogesterone, 17-OH-progesterone, 17-OHP, 17-OH Progesterone, Addison's disease, Adrenal cortex, Amenorrhea, Conn's disease, Cushing's disease, Cycle, Fertility, Hirsutism, Infertility, Sterility, Virilization
| Material |
|
|
| Note |
Optimal blood sampling in the morning, 7:30 - 10:00 h; for women between menarche and menopause during the follicular phase. |
|
| Min. quantity | 500 µL | |
| Stability | 4 days / 18-25°C; 4 days / 2-8°C; 1 year / -20°C | |
| Duration | 2 - 4 days | |
| Frequency | 5 x per week (monday - friday) | |
| Method | Liquid chromatography / mass spectrometry (LCMS) | |
| Price | CHF 61.20 | |
| Tariff | 61.20 TP | |
| LA position | 1002.00 | |
| Designation | 17-alpha-Hydroxyprogesteron |
Reference values
| Value | Age | Sex |
|---|---|---|
| 2.36 - 13.83 nmol/L | 0 - 91 D | f |
| < 12.8 nmol/L | 0 - 3 D | f |
| < 5.2 nmol/L | 4 - 365 D | f |
| 2.72 - 10.80 nmol/L | 92 - 182 D | f |
| 4.36 - 17.49 nmol/L | 183 - 300 D | f |
| 0.1 - 3.5 nmol/L | 1 - 4 Y | f |
| < 2.8 nmol/L | 5 - 9 Y | f |
| < 5.2 nmol/L | 10 - 13 Y | f |
| 0.5 - 8.6 nmol/L | 14 - 17 Y | f |
| . nmol/L | >= 18 Y | f |
| < 12.8 nmol/L | 3 - 3 D | m |
| 0.3 - 5.1 nmol/L | 4 - 365 D | m |
| 0.1 - 3.5 nmol/L | 1 - 4 Y | m |
| < 2.8 nmol/L | 5 - 9 Y | m |
| < 5.2 nmol/L | 10 - 13 Y | m |
| 0.5 - 8.6 nmol/L | 14 - 17 Y | m |
| 1.0 - 9.3 nmol/L | 18 - 30 Y | m |
| 1.3 - 5.9 nmol/L | 31 - 40 Y | m |
| 1.0 - 5.9 nmol/L | 41 - 50 Y | m |
| 1.1 - 3.9 nmol/L | 51 - 70 Y | m |
| 1.0 - 2.0 nmol/L | >= 71 Y | m |
| :Puberty stages nmol/L | 5 - 11 Y | f |
| :according to Tanner: nmol/L | 5 - 11 Y | f |
| P2;P3:<0.5 - 6.7 nmol/L | 5 - 11 Y | f |
| P4;P5:<1.1 - 6.1 nmol/L | 5 - 11 Y | f |
| :Puberty stages nmol/L | 12 - 17 Y | f |
| :according to Tanner: nmol/L | 12 - 17 Y | f |
| P2;P3:<0.5 - 6.7 nmol/L | 12 - 17 Y | f |
| P4;P5:<1.1 - 6.1 nmol/L | 12 - 17 Y | f |
| Follicular:< 5.7 nmol/L | 12 - 17 Y | f |
| luteal phase:< 8.7 nmol/L | 12 - 17 Y | f |
| 1st trimester:2.36 - 13.83 nmol/L | 12 - 70 Y | f |
| 2nd trimester:2.72 - 10.80 nmol/L | 12 - 70 Y | f |
| 3rd trimester:4.36 - 17.49 nmol/L | 12 - 70 Y | f |
| Follicular:< 5.7 nmol/L | 18 - 39 Y | f |
| luteal phase:< 8.7 nmol/L | 18 - 39 Y | f |
| Follicular:< 5.7 nmol/L | 40 - 60 Y | f |
| luteal phase:< 8.7 nmol/L | 40 - 60 Y | f |
| Menopause:< 1.5 nmol/L | 40 - 60 Y | f |
| Menopause:< 1.5 nmol/L | >= 61 Y | f |
| :Puberty stages nmol/L | 5 - 17 Y | m |
| :according to Tanner: nmol/L | 5 - 17 Y | m |
| P2;P3:<0.4 - 3.9 nmol/L | 5 - 17 Y | m |
| P4;P5:<1.5 - 5.7 nmol/L | 5 - 17 Y | m |
Team of consultants
|
MD
Uta Deus
Specialist in General Internal Medicine, FAMH Specialist in laboratory medicine, main field clinical chemistry
|
Specialist in General Internal Medicine, FAMH Specialist in laboratory medicine, main field clinical chemistry | T |
|
|
PhD
Maurus Curti
FAMH Specialist in laboratory medicine, main fields Clinical Chemistry, Haematology, Immunology, Microbiology
|
FAMH Specialist in laboratory medicine, main fields Clinical Chemistry, Haematology, Immunology, Microbiology | T |
|
|
Dr. sc. nat.
Corinne Ruppen
FAMH Specialist in laboratory medicine, main field clinical chemistry
|
FAMH Specialist in laboratory medicine, main field clinical chemistry | T |
|
|
Dr. rer. nat.
Kristina Vollmer
FAMH Specialist in laboratory medicine, main field clinical chemistry
|
FAMH Specialist in laboratory medicine, main field clinical chemistry | T |
|